SCHEMBL5204052

SCHEMBL5204052

CCc1ccc(Oc2cnc(N)[nH]c2=O)cc1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.42
MAPT P10636 1/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
ICAM1 P05362 1/20 0.39
SELE P16581 1/20 0.39
VCAM1 P19320 1/20 0.39
TYMS P04818 2/20 0.39
KDM4C Q9H3R0 1/20 0.39
LTA4H P09960 1/20 0.38
SOD1 P00441 1/20 0.38
NPBWR1 P48145 1/20 0.36
MCHR1 Q99705 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
AURKA O14965 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5202653 0.84 TEAD4 (0.42) MAPTNPC1RAB9AICAM1SELE
SCHEMBL7712501 0.84 XDH (0.45) SMN1; SMN2MAPTTYMSLTA4HKMT2A
SCHEMBL5207036 0.83 KDM4C (0.39) SMN1; SMN2MAPTNPC1RAB9AICAM1
SCHEMBL5207820 0.82 MAPT (0.43) MAPTICAM1SELEVCAM1TYMS
SCHEMBL5202998 0.81 LTA4H (0.57) SMN1; SMN2MAPTKDM4CLTA4HMEN1
SCHEMBL7712456 0.81 MEN1 (0.44) MAPTICAM1SELETYMSLTA4H
SCHEMBL5206240 0.80 NOS1 (0.45) KDM4CLTA4H
SCHEMBL7712398 0.80 TYMS (0.43) TYMSKDM4CLTA4H
SCHEMBL7714536 0.80 NPBWR1 (0.41) ICAM1SELEKDM4CLTA4HNPBWR1
SCHEMBL5206874 0.77 L3MBTL1 (0.41) SMN1; SMN2MAPTRAB9AICAM1SELE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165523-B1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC (US) 2007-11-07 EP disclosed
US-6916820-B1 Neurotrophic substituted pyrimidines KRENITSKY PHARMACEUTICALS, INC. (US) 2005-07-12 US disclosed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US disclosed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed